[Hemostatic therapy for hemorrhagic cholecystitis in a patient with hemophilia A with inhibitors].
Shuji Ozaki(Tokushima Prefectural Central Hospital), Kumiko Kagawa(Tokushima Prefectural Central Hospital), Makiko Mizuguchi(Tokushima Prefectural Central Hospital), Yusuke Arakawa(Tokushima Prefectural Central Hospital), Yasunobu Okamoto(Tokushima Prefectural Central Hospital), Toshihiro Omoya(Tokushima Prefectural Central Hospital), Hiroyoshi Watanabe(Tokushima University), Hironobu Shibata(Tokushima Prefectural Central Hospital)
Cited by 0
Related Papers
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
|Leukemia|2017|356
Factors associated with granulocyte colony‐stimulating factor‐induced peripheral blood stem cell yield in healthy donors
|Vox Sanguinis|2005|118
Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking
|Transfusion|2004|114
The first selective linear codimerization of terminal acetylenes and 1,3-dienes catalyzed by dihydridotetrakis(trialkylphosphine)ruthenium complexes
|The Journal of Organic Chemistry|1985|89
Synthetic Studies of Vitamin D Analogues. XIV. Synthesis and Calcium Regulating Activity of Vitamin D3 Analogues Bearing a Hydroxyalkoxy Group at the 2.BETA.-Position.
|Chemical and Pharmaceutical Bulletin|1993|82